Sanofi And Lexicon Fall Out Over Zynquista, As French Group Exits Diabetes Pact

Swift exit
Sanofi ‘walks’ from R&D Pact investigating Lexicon’s Zynquista in diabetes • Source: Shutterstock

More from Business

More from Scrip